Investigation of a targeted panel of gut microbiome–derived toxins in children with chronic kidney disease
Pediatric Nephrology · 2025
DOI: 10.1007/s00467-024-06580-6 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Nephrology, 2025. Verfasst von Mina Ebrahimi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Drexel College of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCCIH NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: The gut-kidney axis is implicated in chronic kidney disease (CKD) morbidity. We describe how a panel of gut microbiome-derived toxins relates to kidney function and neurocognitive outcomes in children with CKD, consisting of indoleacetate, 3-indoxylsulfate, p-cresol glucuronide, p-cresol sulfate, and phenylacetylglutamine. METHODS: The Chronic Kidney Disease in Children (CKiD) cohort is a North American multicenter prospective cohort that enrolled children aged 6 months to 16 years with estimated glomerular filtration rate (eGFR) 30-89 ml/min/1.73 m2. Data from the 2-year study visit were used for this analysis. Toxin quantification (Metabolon Inc., Durham, NC) was performed with ultra-high performance liquid chromatography/tandem mass spectrometry. Executive function and echocardiograms were assessed. Regression analysis examined the association of toxin levels with eGFR, CKD etiology, and neurocognitive and cardiac assessments (adjusted for age, sex, and urine protein:creatinine [UPCR]). RESULTS: There were 150 CKiD participants included in this study. All toxins levels were significantly inversely correlated with eGFR (Spearman's rho - 0.45 to - 0.69). Children with non-glomerular CKD had significantly higher levels of 3-indoxylsulfate, phenylacetylglutamine, and p-cresol glucuronide. The toxin levels did not associate with neurocognitive outcomes. P-cresol glucuronide and phenylacetylglutamine negatively associated with left ventricular mass index z score, but did not associate with left ventricular hypertrophy. CONCLUSIONS: Children with CKD have high levels of circulating gut microbiome-derived toxins. The levels of these toxins are strongly correlated with eGFR. There appear to be differences in toxin level based on glomerular versus non-glomerular etiology, even when accounting for the differences in eGFR between these two subgroups. In this sample, we did not detect any associations between these toxin levels and neurocognitive or cardiac outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drexel College of Medicine, Philadelphia, PA, USA.
- Department of Health Sciences, School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
- Division of Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- School of Public Health, University of Texas San Antonio, San Antonio, TX, USA.
- Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
- Division of Nephrology, Children's Mercy Kansas City, Kansas City, MO, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NCCIH NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Complementary and Integrative Health
- National Heart, Lung, and Blood Institute
- National Institute of Corrections
Zitieren
APA
Ebrahimi, M., Hooper, S. R., Mitsnefes, M. M., Vasan, R. S., Kimmel, P. L., Warady, B. A., Furth, S. L., Hartung, E. A., Denburg, M. R., & Lee, A. M. (2025). Investigation of a targeted panel of gut microbiome–derived toxins in children with chronic kidney disease. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06580-6
Vancouver
Ebrahimi M, Hooper SR, Mitsnefes MM, Vasan RS, Kimmel PL, Warady BA, et al. Investigation of a targeted panel of gut microbiome–derived toxins in children with chronic kidney disease. Pediatric Nephrology. 2025. doi:10.1007/s00467-024-06580-6
BibTeX
@article{Ebrahimi2025,
author = {Ebrahimi, Mina and Hooper, Stephen R and Mitsnefes, Mark M and Vasan, Ramachandran S and Kimmel, Paul L and Warady, Bradley A and Furth, Susan L and Hartung, Erum A and Denburg, Michelle R and Lee, Arthur M},
title = {Investigation of a targeted panel of gut microbiome–derived toxins in children with chronic kidney disease},
journal = {Pediatric Nephrology},
year = {2025},
doi = {10.1007/s00467-024-06580-6}
}
EUVIMED